SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-23-008248
Filing Date
2023-05-17
Accepted
2023-05-17 21:11:09
Documents
1
Period of Report
2023-05-16

Document Format Files

Seq Description Document Type Size
1 form4-05182023_010502.html 4  
1 form4-05182023_010502.xml 4 4101
  Complete submission text file 0001415889-23-008248.txt   5551
Mailing Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142 617-417-5868
Black Diamond Therapeutics, Inc. (Issuer) CIK: 0001701541 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O VERSANT VENTURES, AESCHENVORSTADT 36 BASEL V8 4051
Business Address
Mayweg Alexander (Reporting) CIK: 0001786260 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39200 | Film No.: 23933549